Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Metadata
Title
Improving the prediction of response to therapy in autism
Authors
Stephen Bent
Robert L. Hendren
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 3/2010
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1016/j.nurt.2010.05.011

Other articles of this Issue 3/2010

Neurotherapeutics 3/2010 Go to the issue

Review Article

Immune therapy in autism: Historical experience and future directions with immunomodulatory therapy

Editorial

Neurotherapeutics to publish primary research papers

Review Article

Immune dysfunction in autism: A pathway to treatment

Review Article

Medical comorbidities in autism: Challenges to diagnosis and treatment

Editorial

Shifting the paradigm for autism treatments

Review Article

Aripiprazole in autism spectrum disorders and fragile X syndrome